News Releases | Olink Holding AB

Date	Title
Mar 21, 2023	Bruno Rossi joins Olink as Chief Commercial Officer
Mar 15, 2023	Notice to attend the Annual General Meeting of Olink Holding AB (publ)
Mar 06, 2023	NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
Feb 28, 2023	Olink establishes agreement with Regeneron Genetics Center to scale their proteomics efforts, potentially enabling a new era of drug discovery
Feb 21, 2023	Olink reports fourth quarter and full year 2022 financial results
Jan 18, 2023	Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares
Jan 18, 2023	Olink Holding AB (publ) launches public offering of American Depositary Shares
Jan 09, 2023	Olink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023
Dec 29, 2022	Olink to participate in the 41st Annual JP Morgan Healthcare Conference
Nov 17, 2022	Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award
Nov 14, 2022	Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification
Nov 10, 2022	Olink reports third quarter 2022 financial results
Nov 03, 2022	Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology
Nov 01, 2022	Olink to participate in November investor events
Oct 24, 2022	Announcing Olink® Insight, a digital knowledge-sharing platform to amplify the value of proteomics data
Oct 13, 2022	Olink to report third quarter 2022 financial results on November 10, 2022
Sep 20, 2022	Discovery Life Sciences partners with Olink to support proteomics research and accelerate precision medicine programs
Sep 15, 2022	Multi-omics service provider Sequanta completes extended concordance validation of Olink® Target 48/96 and Olink® Explore
Aug 31, 2022	Olink strengthens management team for continued leadership in the modern proteomics era
Aug 30, 2022	Olink to participate in September investor conferences